{"id":7563,"date":"2026-05-19T01:00:00","date_gmt":"2026-05-18T23:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=9d0fb23ce466d6075a8d0c5d0f79cf2c"},"modified":"2026-05-19T01:00:00","modified_gmt":"2026-05-18T23:00:00","slug":"maravai-lifesciences-to-attend-the-jefferies-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=7563","title":{"rendered":"Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference"},"content":{"rendered":"<p>SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference in June.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260518944378\/en\/2611206\/5\/Maravai_Logo_CMYK%5B29%5D-01.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260518944378\/en\/2611206\/22\/Maravai_Logo_CMYK%5B29%5D-01.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260518944378\/en\/2611206\/5\/Maravai_Logo_CMYK%5B29%5D-01.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260518944378\/en\/2611206\/21\/Maravai_Logo_CMYK%5B29%5D-01.jpg\" \/><\/a><p>\nOn June 4, 2026, at 12:50 p.m. Eastern Time, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City, NY.<\/p><p>\nA live webcast of the fireside chat will be on the Maravai LifeSciences <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.maravai.com%2F&amp;esheet=54537766&amp;newsitemid=20260518944378&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=1&amp;md5=e0cbe548c9199177f66af5c4c7cd24ae\" rel=\"nofollow\" shape=\"rect\">Investor Relations<\/a> website, under News &amp; Events, IR Calendar. An archived replay of the webcast will also be available on the website following the event.<\/p><p>\n<b>About Maravai<\/b><\/p><p>\nMaravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai\u2019s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world\u2019s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.<\/p><p>\nFor more information about Maravai LifeSciences, visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.maravai.com&amp;esheet=54537766&amp;newsitemid=20260518944378&amp;lan=en-US&amp;anchor=www.maravai.com&amp;index=2&amp;md5=530b4ee6c0afa5466040d3330a5ce500\" rel=\"nofollow\" shape=\"rect\">www.maravai.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nInvestor Contact:\n<br\/>Deb Hart\n<br\/>Maravai LifeSciences\n<br\/>+1 858-988-5917\n<br\/><a  href=\"mailto:ir@maravai.com\" rel=\"nofollow\" shape=\"rect\">ir@maravai.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7563","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/7563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7563"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/7563\/revisions"}],"predecessor-version":[{"id":7564,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/7563\/revisions\/7564"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}